# Timely Recovery After Subclinical Heart Failure

Study · id `cardio:ct-nct06341101` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06341101](<https://clinicaltrials.gov/study/NCT06341101>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06341101

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: High blood pressure; Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.

## Technical summary

Registry record NCT06341101. Randomized; no masking; primary purpose treatment. Start 2024-03-26 (anticipated); primary completion 2026-03-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 130 participants (planned count; ClinicalTrials.gov record NCT06341101, source copy `cardio:ctgov-nct06341101-2024-04-02`, retrieved 2026-10-26)
- Planned start: 2024-03-26 (anticipated) (ClinicalTrials.gov record NCT06341101, source copy `cardio:ctgov-nct06341101-2024-04-02`, retrieved 2026-10-26)
- Primary completion: 2026-03-01 (anticipated) (ClinicalTrials.gov record NCT06341101, source copy `cardio:ctgov-nct06341101-2024-04-02`, retrieved 2026-10-26)
- Completion: 2026-03-01 (anticipated) (ClinicalTrials.gov record NCT06341101, source copy `cardio:ctgov-nct06341101-2024-04-02`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT06341101, source copy `cardio:ctgov-nct06341101-2024-04-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06341101-2024-04-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Timely Recovery After Subclinical Heart Failure
- Acronym: TREASURE
- Condition: Heart Failure
- Condition: Diastolic Dysfunction
- Intervention (Drug): Perindopril
- Lead sponsor: Academisch Ziekenhuis Maastricht
- Lead sponsor class: OTHER
- Collaborator: ZonMw: The Netherlands Organisation for Health Research and Development
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as a collaborator: ZonMw: The Netherlands Organisation for Health Research and Development (`cardio:org-zonmw-the-netherlands-organisation-for-health-research-and-cc2e75`)

## Provenance

Content hash: 1efb9be139556fc3f6d31495ab247bad4fd5dda99d84679e11812fee35d99b44
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
